Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.
暂无分享,去创建一个
R. Vile | J. Chester | T. Kottke | L. Sanz | J. Qiao | R. Díaz | Jill Thompson | L. Sanchez-Perez | U. Thanarajasingam
暂无分享,去创建一个
R. Vile | J. Chester | T. Kottke | L. Sanz | J. Qiao | R. Díaz | Jill Thompson | L. Sanchez-Perez | U. Thanarajasingam